JP2005505247A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005505247A5 JP2005505247A5 JP2002578401A JP2002578401A JP2005505247A5 JP 2005505247 A5 JP2005505247 A5 JP 2005505247A5 JP 2002578401 A JP2002578401 A JP 2002578401A JP 2002578401 A JP2002578401 A JP 2002578401A JP 2005505247 A5 JP2005505247 A5 JP 2005505247A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- amino acid
- group
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims description 57
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 12
- 230000003902 lesions Effects 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 7
- 230000000051 modifying Effects 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 230000003334 potential Effects 0.000 claims description 3
- 150000007523 nucleic acids Chemical group 0.000 claims 33
- 108020004707 nucleic acids Proteins 0.000 claims 28
- 239000000523 sample Substances 0.000 claims 19
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 14
- 150000001413 amino acids Chemical class 0.000 claims 11
- 239000002773 nucleotide Substances 0.000 claims 11
- 125000003729 nucleotide group Chemical group 0.000 claims 11
- 239000000126 substance Substances 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 8
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 230000000295 complement Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229920001405 Coding region Polymers 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 230000001594 aberrant Effects 0.000 claims 2
- 102000004965 antibodies Human genes 0.000 claims 2
- 108090001123 antibodies Proteins 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920000023 polynucleotide Polymers 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- 210000001519 tissues Anatomy 0.000 claims 2
- 230000001413 cellular Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 201000010874 syndrome Diseases 0.000 claims 1
Applications Claiming Priority (46)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27428101P | 2001-03-08 | 2001-03-08 | |
| US27419401P | 2001-03-08 | 2001-03-08 | |
| US27432201P | 2001-03-08 | 2001-03-08 | |
| US27484901P | 2001-03-09 | 2001-03-09 | |
| US27557801P | 2001-03-13 | 2001-03-13 | |
| US27557901P | 2001-03-13 | 2001-03-13 | |
| US27560101P | 2001-03-13 | 2001-03-13 | |
| US27600001P | 2001-03-14 | 2001-03-14 | |
| US27677601P | 2001-03-16 | 2001-03-16 | |
| US27699401P | 2001-03-19 | 2001-03-19 | |
| US27733801P | 2001-03-20 | 2001-03-20 | |
| US27723901P | 2001-03-20 | 2001-03-20 | |
| US27732701P | 2001-03-20 | 2001-03-20 | |
| US27779101P | 2001-03-21 | 2001-03-21 | |
| US27783301P | 2001-03-22 | 2001-03-22 | |
| US27815201P | 2001-03-23 | 2001-03-23 | |
| US27889401P | 2001-03-26 | 2001-03-26 | |
| US27899901P | 2001-03-27 | 2001-03-27 | |
| US27903601P | 2001-03-27 | 2001-03-27 | |
| US28023301P | 2001-03-30 | 2001-03-30 | |
| US28080201P | 2001-04-02 | 2001-04-02 | |
| US28822801P | 2001-05-02 | 2001-05-02 | |
| US28806601P | 2001-05-02 | 2001-05-02 | |
| US28805201P | 2001-05-02 | 2001-05-02 | |
| US29176601P | 2001-05-17 | 2001-05-17 | |
| US29669301P | 2001-06-07 | 2001-06-07 | |
| US29685601P | 2001-06-08 | 2001-06-08 | |
| US30323001P | 2001-07-05 | 2001-07-05 | |
| US30323701P | 2001-07-05 | 2001-07-05 | |
| US31091301P | 2001-08-08 | 2001-08-08 | |
| US31197801P | 2001-08-13 | 2001-08-13 | |
| US31219101P | 2001-08-14 | 2001-08-14 | |
| US31291601P | 2001-08-16 | 2001-08-16 | |
| US31318201P | 2001-08-17 | 2001-08-17 | |
| US31362601P | 2001-08-20 | 2001-08-20 | |
| US31401801P | 2001-08-21 | 2001-08-21 | |
| US31522701P | 2001-08-27 | 2001-08-27 | |
| US31851001P | 2001-09-10 | 2001-09-10 | |
| US31840301P | 2001-09-10 | 2001-09-10 | |
| US32236001P | 2001-09-14 | 2001-09-14 | |
| US32229601P | 2001-09-14 | 2001-09-14 | |
| US32537801P | 2001-09-27 | 2001-09-27 | |
| US33248601P | 2001-11-09 | 2001-11-09 | |
| US34539901P | 2001-11-09 | 2001-11-09 | |
| US10/094,886 US20040002120A1 (en) | 2001-03-08 | 2002-03-07 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| PCT/US2002/007355 WO2002079398A2 (fr) | 2001-03-08 | 2002-03-08 | Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005505247A JP2005505247A (ja) | 2005-02-24 |
| JP2005505247A5 true JP2005505247A5 (fr) | 2006-01-05 |
Family
ID=29274020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002578401A Pending JP2005505247A (ja) | 2001-03-08 | 2002-03-08 | 治療用ポリペプチド、該ポリペプチドをコードする核酸、および使用方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2005505247A (fr) |
| CA (1) | CA2440108A1 (fr) |
-
2002
- 2002-03-08 CA CA002440108A patent/CA2440108A1/fr not_active Abandoned
- 2002-03-08 JP JP2002578401A patent/JP2005505247A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003505075A5 (fr) | ||
| JP2005512515A5 (fr) | ||
| JP2019056013A (ja) | ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療 | |
| US20200330555A1 (en) | Methods of treating gastrointestinal motility-related disorders using variants and fusions of fgf19/fgf21 polypeptides | |
| JP2000078991A (ja) | ヒト・ナトリウム依存性リン酸輸送体（ｉｐｔ―１） | |
| BR122016021558A2 (pt) | Polipeptídeos isolados, seus usos, e composição farmacêutica | |
| JP2000093186A (ja) | Ｆｒｉｚｚｌｅｄ―４ポリペプチドおよびＦｒｉｚｚｌｅｄ―４ポリヌクレオチド | |
| JP2003532742A (ja) | 神経損傷の修復 | |
| BR112021013874A2 (pt) | Composição de ácido nucleico, vetor de terapia de gene de mamífero, partícula de vírus adeno-associado, métodos para tratar hemofilia a e para produzir uma partícula de vírus adeno-associado, e, uso de uma composição de ácido nucleico e de um vetor de terapia de gene de mamífero | |
| JP2002281985A (ja) | Ｍｂｇｐ１ポリペプチドおよびポリヌクレオチド | |
| JPH1175873A (ja) | 新規化合物 | |
| ES2582559T3 (es) | Factor trófico para el tratamiento de las enfermedades degenerativas de la retina | |
| JP2004533235A5 (fr) | ||
| JP2005528080A5 (fr) | ||
| JPH1142092A (ja) | ヒト心臓／脳トロイド様タンパク質 | |
| JPH1118786A (ja) | 腫瘍壊死関連受容体ｔｒ７ | |
| JP2005505247A5 (fr) | ||
| JP2005506833A5 (fr) | ||
| JPH1175874A (ja) | 新規化合物 | |
| JPH1198989A (ja) | 新規化合物 | |
| JP2005507236A5 (fr) | ||
| JP2000512506A (ja) | 新規化合物 | |
| JPH11151094A (ja) | 免疫グロブリン遺伝子スーパーファミリーのメンバーｐｉｇｒｌ−１ | |
| JP2004512310A (ja) | 新規用途 | |
| WO2002030974A2 (fr) | Nouvelles proteines et acides nucleiques codant pour celles-ci |